BioSpace News Archive

Hologic, Inc. announced that the Company will present at these upcoming virtual investor conferences

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of the Reliance SARS-CoV-2 RT-PCR Kit (IVD) for European markets after having met the CE-IVD mark requirements.

Aquestive Therapeutics, Inc. (NASDAQ:AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic problems, today reported financial results for the first quarter ended March 31, 2021 and provided an update on recent developments in its business.

Posters highlight ensifentrine’s safety profile and its potential to improve lung function and quality of life irrespective of COPD severity

Evotec SE and the University Hospital Erlangen announced a partnership regarding molecular analyses of biospecimens from the German Chronic Kidney Disease cohort study.

Vicore Pharma Holding AB, a rare disease pharmaceutical company developing innovative medicines for fibrotic lung disorders such as idiopathic pulmonary fibrosis, announces the signing of an agreement with Alex Therapeutics AB for the development and clinical validation of a digital therapeutic built on the “Alex DTx Platform”.

Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces the participation of members of the company’s senior management team in three R&D and investor conferences being held virtually during May 2021.

HUTCHMED Limited, formerly known as Hutchison China MediTech Limited, announces that, further to its “Results of Annual General Meeting” announcement released on Wednesday, April 28, 2021, the Registrar of Companies in the Cayman Islands has issued a replacement certificate of incorporation on Thursday, April 29, 2021 in the name of HUTCHMED Limited so the new name of the Company is now effective from April 29, 2021.

Invitation to join the presentation of C-RAD’s first quarter 2021. CEO Tim Thurn will also give his Annual General Meeting speech at this event.

NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced that a peer-reviewed publication using the GeoMx® Digital Spatial Profiler is to be published in the journal Nature.